Effect of pre‐transplant JAK1/2 inhibitors and CD34 dose on transplant outcomes in Myelofibrosis
Keyword(s):
2021 ◽
Vol 40
(4)
◽
pp. S429-S430
Keyword(s):
2021 ◽
Vol 40
(4)
◽
pp. S256
Keyword(s):
2021 ◽
Vol 40
(4)
◽
pp. S364
Keyword(s):